The antagonism between reserpine and some antiparkinson drugs in electroseizure.
D000433:1-Propanol; D000818:Animals; D001285:Atropine / Q000494:pharmacology*; D001712:Biperiden / Q000494:pharmacology; D003510:Cyclohexanes; D003913:Dextroamphetamine / Q000494:pharmacology*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004597:Electroshock; D008694:Methamphetamine / Q000494:pharmacology*; D010276:Parasympatholytics / Q000494:pharmacology*; D010880:Piperidines / Q000494:pharmacology*; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors*; D013566:Sympathomimetics; D013618:Tachyphylaxis; D013747:Tetrabenazine / Q000037:antagonists & inhibitors; D013859:Thiocarbamates / Q000494:pharmacology; D014443:Tyrosine / Q000494:pharmacology
D003510:Cyclohexanes; D010276:Parasympatholytics; D010880:Piperidines; D013566:Sympathomimetics; D013859:Thiocarbamates; D001712:Biperiden; D014443:Tyrosine; D008694:Methamphetamine; D004295:Dihydroxyphenylalanine; D001285:Atropine; D012110:Reserpine; D000433:1-Propanol; D003913:Dextroamphetamine; D013747:Tetrabenazine